About: Maftivimab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

Maftivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).

Property Value
dbo:abstract
  • Maftivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus). (en)
dbo:casNumber
  • 2135632-36-7
dbo:class
dbo:fdaUniiCode
  • KOP95331M4
dbo:kegg
  • D11450
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 65587393 (xsd:integer)
dbo:wikiPageLength
  • 4767 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1011364704 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 6368 (xsd:integer)
dbp:casNumber
  • 2135632 (xsd:integer)
dbp:class
dbp:dailymedid
  • Maftivimab (en)
dbp:h
  • 9886 (xsd:integer)
dbp:kegg
  • D11450 (en)
dbp:mabType
  • mab (en)
dbp:n
  • 1706 (xsd:integer)
dbp:o
  • 2008 (xsd:integer)
dbp:pregnancyUs
  • N (en)
dbp:pronounce
  • maf tiv' i mab (en)
dbp:s
  • 46 (xsd:integer)
dbp:source
  • u (en)
dbp:target
  • Zaire ebolavirus glycoprotein (en)
dbp:type
  • mab (en)
dbp:unii
  • KOP95331M4 (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Maftivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus). (en)
rdfs:label
  • Maftivimab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License